Ensysce Biosciences CEO Lynn Kirkpatrick's 2023 pay slips 18% to $509K
Ensysce Biosciences reports 2023 executive compensation
By ExecPay News
Published: 10 hours ago
Ensysce Biosciences reported fiscal year 2023 executive compensation information on October 17, 2024.
In 2023, three executives at Ensysce Biosciences received on average a compensation package of $448K, a 30% decrease compared to previous year.
Average pay of disclosed executives at Ensysce Biosciences
Lynn Kirkpatrick, Chief Executive Officer, received $509K in total, which decreased by 18% compared to 2022. 80% of Kirkpatrick's compensation, or $405K, was in salary. Kirkpatrick also received $94K in option awards and $9.9K in other compensation.
Dave Humphrey, Chief Financial Officer, received a compensation package of $442K, which decreased by 43% compared to previous year. 77% of the compensation package, or $338K, was in salary.
Geoff Birkett, Chief Commercial Officer, earned $392K in 2023, a 7% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on October 17, 2024.